Foghorn Therapeutics Inc. (FHTX)

Foghorn Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	241	262	272	267	848	721
Market Cap Growth	-28.93%	-3.64%	2.10%	-68.56%	17.59%	-
Enterprise Value	55	34	59	-54	807	894
Last Close Price	4.33	4.72	6.45	6.38	22.87	20.27
PS Ratio	11.05	11.61	7.97	13.87	643.15	1677.72
PB Ratio	-3.91	-5.76	-3.53	2381.22	8.76	4.93
P/TBV Ratio	-	-	-	2381.22	8.76	4.93
P/FCF Ratio	-	-	-	1.39	-	-
P/OCF Ratio	-	-	-	1.38	-	-
EV/Sales Ratio	2.34	1.51	1.74	-	612.13	2079.55
Debt / Equity Ratio	-0.56	-0.82	-0.58	459.88	0.60	0.56
Debt / FCF Ratio	-	-	-	0.27	-	-
Asset Turnover	0.09	0.08	0.10	0.04	0.00	0.00
Quick Ratio	3.09	3.64	4.01	6.26	9.33	9.86
Current Ratio	3.16	3.73	4.11	6.37	9.44	10.12
Return on Equity (ROE)	-	-	-	-224.54%	-83.37%	-95.05%
Return on Assets (ROA)	-23.12%	-22.00%	-19.53%	-15.83%	-16.24%	-30.82%
Return on Capital (ROIC)	-	-	-691.63%	-70.80%	-32.84%	-35.20%
Earnings Yield	-33.40%	-33.01%	-36.15%	-40.83%	-11.94%	-9.54%
FCF Yield	-39.81%	-38.61%	-43.82%	72.14%	-6.31%	-6.58%
Buyback Yield / Dilution	-42.43%	-30.79%	-0.92%	-11.89%	-236.49%	-163.53%

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q